Your browser doesn't support javascript.
loading
The BRG1/SOX9 axis is critical for acinar cell-derived pancreatic tumorigenesis.
Tsuda, Motoyuki; Fukuda, Akihisa; Roy, Nilotpal; Hiramatsu, Yukiko; Leonhardt, Laura; Kakiuchi, Nobuyuki; Hoyer, Kaja; Ogawa, Satoshi; Goto, Norihiro; Ikuta, Kozo; Kimura, Yoshito; Matsumoto, Yoshihide; Takada, Yutaka; Yoshioka, Takuto; Maruno, Takahisa; Yamaga, Yuichi; Kim, Grace E; Akiyama, Haruhiko; Ogawa, Seishi; Wright, Christopher V; Saur, Dieter; Takaori, Kyoichi; Uemoto, Shinji; Hebrok, Matthias; Chiba, Tsutomu; Seno, Hiroshi.
Afiliação
  • Tsuda M; Department of Gastroenterology and Hepatology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
  • Fukuda A; Department of Gastroenterology and Hepatology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
  • Roy N; Diabetes Center, Department of Medicine, UCSF, San Francisco, California, USA.
  • Hiramatsu Y; Department of Gastroenterology and Hepatology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
  • Leonhardt L; Diabetes Center, Department of Medicine, UCSF, San Francisco, California, USA.
  • Kakiuchi N; Department of Gastroenterology and Hepatology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
  • Hoyer K; Department of Pathology and Tumor Biology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
  • Ogawa S; Department of Pathology and Tumor Biology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
  • Goto N; Hematology, Oncology and Tumorimmunology, Charite-Universitätsmedizin Berlin, Berlin, Germany.
  • Ikuta K; Department of Gastroenterology and Hepatology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
  • Kimura Y; Department of Gastroenterology and Hepatology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
  • Matsumoto Y; Department of Gastroenterology and Hepatology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
  • Takada Y; Department of Gastroenterology and Hepatology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
  • Yoshioka T; Department of Gastroenterology and Hepatology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
  • Maruno T; Department of Gastroenterology and Hepatology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
  • Yamaga Y; Department of Gastroenterology and Hepatology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
  • Kim GE; Department of Gastroenterology and Hepatology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
  • Akiyama H; Department of Gastroenterology and Hepatology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
  • Ogawa S; Department of Pathology, UCSF, San Francisco, California, USA.
  • Wright CV; Department of Orthopaedics, Gifu University, Gifu, Japan.
  • Saur D; Department of Pathology and Tumor Biology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
  • Takaori K; Program in Developmental Biology and Department of Cell and Developmental Biology, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
  • Uemoto S; Department of Internal Medicine II, Klinikum Rechts der Isar, Technische Universität München, Munich, Germany.
  • Hebrok M; Division of Hepatobiliary-Pancreatic Surgery and Transplantation, Department of Surgery, Kyoto University Graduate School of Medicine, Kyoto, Japan.
  • Chiba T; Division of Hepatobiliary-Pancreatic Surgery and Transplantation, Department of Surgery, Kyoto University Graduate School of Medicine, Kyoto, Japan.
  • Seno H; Diabetes Center, Department of Medicine, UCSF, San Francisco, California, USA.
J Clin Invest ; 128(8): 3475-3489, 2018 08 01.
Article em En | MEDLINE | ID: mdl-30010625
Chromatin remodeler Brahma related gene 1 (BRG1) is silenced in approximately 10% of human pancreatic ductal adenocarcinomas (PDAs). We previously showed that BRG1 inhibits the formation of intraductal pancreatic mucinous neoplasm (IPMN) and that IPMN-derived PDA originated from ductal cells. However, the role of BRG1 in pancreatic intraepithelial neoplasia-derived (PanIN-derived) PDA that originated from acinar cells remains elusive. Here, we found that exclusive elimination of Brg1 in acinar cells of Ptf1a-CreER; KrasG12D; Brg1fl/fl mice impaired the formation of acinar-to-ductal metaplasia (ADM) and PanIN independently of p53 mutation, while PDA formation was inhibited in the presence of p53 mutation. BRG1 bound to regions of the Sox9 promoter to regulate its expression and was critical for recruitment of upstream regulators, including PDX1, to the Sox9 promoter and enhancer in acinar cells. SOX9 expression was downregulated in BRG1-depleted ADMs/PanINs. Notably, Sox9 overexpression canceled this PanIN-attenuated phenotype in KBC mice. Furthermore, Brg1 deletion in established PanIN by using a dual recombinase system resulted in regression of the lesions in mice. Finally, BRG1 expression correlated with SOX9 expression in human PDAs. In summary, BRG1 is critical for PanIN initiation and progression through positive regulation of SOX9. Thus, the BRG1/SOX9 axis is a potential target for PanIN-derived PDA.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Fatores de Transcrição / Proteínas Nucleares / Transdução de Sinais / Transformação Celular Neoplásica / DNA Helicases / Carcinoma Ductal Pancreático / Fatores de Transcrição SOX9 Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans / Male Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Fatores de Transcrição / Proteínas Nucleares / Transdução de Sinais / Transformação Celular Neoplásica / DNA Helicases / Carcinoma Ductal Pancreático / Fatores de Transcrição SOX9 Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans / Male Idioma: En Ano de publicação: 2018 Tipo de documento: Article